Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).
The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinical insight to the results statements.
The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.
MedTech, Genetic Diagnostics, Medical Research, Healthcare